Pitching Endpoints News Science Reporters: Vertical Press Strategy
Endpoints News is a specialist biopharma publication built for industry insiders, not general readers. Pitching its Science desk requires drug-development literacy, hard data, and a clear "why it matters now" hook.
This guide distills how to reach the Endpoints News Science reporters covering the beat — and what to skip.
Editorial Scope: What Endpoints News Covers in Science#
The Science beat sits at the intersection of biology, clinical evidence, and commercial consequence. Expect coverage of trial readouts, platform science (cell/gene therapy, mRNA, ADCs), translational research, and regulatory-adjacent science.
Endpoints favors stories with a mechanism angle and a market implication. Pure academic novelty rarely clears the bar unless it signals a therapeutic shift.
💡 Vertical Pro Tip: Lead with the clinical or commercial stake, not the journal citation. Endpoints readers want to know what the science means for pipelines, patients, and valuations.
Identifying Active Writers on the Endpoints News Science Reporters List#
The beat is staffed by 5+ active journalists, so routing your pitch correctly is half the battle. Our directory lists representatives including Elizabeth Cairns, Reynald Castaneda, Kyle LaHucik, and Jared Whitlock.
Check recent bylines before sending — beat assignments shift. A current Endpoints News Science reporters list beats a stale media database every time.
| Factor | Recommended Strategy | What Gets Ignored |
|---|---|---|
| Beat fit | Match pitch to writer's recent bylines | Blast emails to the whole desk |
| News hook | Tie to a readout, filing, or data drop | "Evergreen" thought leadership |
| Evidence | Include effect sizes, endpoints, p-values | Vague "breakthrough" claims |
| Timing | Pitch 24–72 hours pre-embargo lift | Post-announcement catch-up notes |
| Access | Offer the scientist or CMO directly | Press releases with no interview |
Angles & Data Points That Resonate With Endpoints News Science Journalists#
Endpoints News Science journalists reward specificity. Bring the trial design, the endpoint, and the delta versus standard of care in the first paragraph.
Strong angles: mechanism differentiation, biomarker strategy, manufacturing or CMC constraints, and safety signals. Controversy backed by data performs well.
Weak angles: funding rounds framed as science, undifferentiated "AI drug discovery" pitches, and embargoed PR with no independent voice.
Outreach Protocols & Accessing Endpoints News Science Journalists Contacts#
Keep the initial email under 150 words with the news peg, the data, and an offer of an interview. Attach nothing on first contact — link instead.
For Endpoints News Science journalists contacts, source verified emails through the outlet's masthead and byline pages, and cross-reference with our directory. Personalize each send with a reference to prior coverage.
Follow up once after 48–72 hours, then stop. Respect embargoes precisely; Endpoints tracks breaches.
Fast-Action Pitch Checklist for Science#
- News hook tied to a readout, filing, or data release
- Key efficacy/safety numbers in the subject line or first line
- Named scientist or executive available for interview
- Correct writer identified from recent bylines
- Embargo terms stated clearly and honored
- One follow-up scheduled, then no further chasing
Pitch the science with commercial clarity, and the Endpoints News Science reporters will take the call.